The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...

Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer's ...

Rising prevalence, aging populations, and therapeutic innovation are reshaping the landscape of multiple myeloma care and ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

There’s a lot gone on since [the last guideline was published in] 2014, and it now doesn’t reflect best practice,’ said ...

Interim data from ENERGY 3 trial highlight INZ-701's potential to modify disease course in ENPP1 Deficiency, with sustained ...

A NEW PUBLICATION IN THE SCIENTIFIC JOURNAL PLOS ONE, SHOWS THAT MASITINIB CAN LOWER SERUM NEUROFILAMENT LIGHT CHAIN, AN IMPORTANT BIOMARKER FOR NEURODEGENERATIVE DISORDERS, INCLUDING MULTIPLE ...

The CORDELIA study combines data from 35 Spanish cohorts (n = 196,632) to investigate genetic, clinical, and lifestyle risk ...

The Global Serological Testing Market will witness a growth rate of 6-8% by 2027. The global serological testing market is ...

The Trade-Adverse Trade Adviser: Once sidelined, President Trump’s counselor Peter Navarro has returned to Washington and ...

Ibrahim Ali Khan revealed his childhood speech struggle due to jaundice-induced hearing loss. He continues speech therapy, ...

Antech™, a global veterinary diagnostics, technology and imaging company, today announced the launch of two new vector-borne disease diagnostics in their expanding portfolio: enhanced Accuplex™, a ...